- Home
- HXHX vs NERV Comparison
HXHX vs NERV Comparison
Compare HXHX & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- NERV
- Stock Information
- Founded
- HXHX 2003
- NERV 2007
- Country
- HXHX China
- NERV United States
- Employees
- HXHX N/A
- NERV N/A
- Industry
- HXHX Trucking Freight/Courier Services
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- NERV Health Care
- Exchange
- HXHX Nasdaq
- NERV Nasdaq
- Market Cap
- HXHX 16.8M
- NERV 14.6M
- IPO Year
- HXHX 2025
- NERV 2014
- Fundamental
- Price
- HXHX $1.27
- NERV $2.50
- Analyst Decision
- HXHX
- NERV Hold
- Analyst Count
- HXHX 0
- NERV 1
- Target Price
- HXHX N/A
- NERV $5.00
- AVG Volume (30 Days)
- HXHX 179.3K
- NERV 686.7K
- Earning Date
- HXHX 11-20-2025
- NERV 11-04-2025
- Dividend Yield
- HXHX N/A
- NERV N/A
- EPS Growth
- HXHX N/A
- NERV N/A
- EPS
- HXHX 0.26
- NERV 1.48
- Revenue
- HXHX $25,571,810.00
- NERV N/A
- Revenue This Year
- HXHX N/A
- NERV N/A
- Revenue Next Year
- HXHX N/A
- NERV N/A
- P/E Ratio
- HXHX $4.88
- NERV $1.68
- Revenue Growth
- HXHX N/A
- NERV N/A
- 52 Week Low
- HXHX $0.84
- NERV $1.15
- 52 Week High
- HXHX $6.29
- NERV $3.29
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- NERV 56.92
- Support Level
- HXHX N/A
- NERV $2.39
- Resistance Level
- HXHX N/A
- NERV $2.72
- Average True Range (ATR)
- HXHX 0.00
- NERV 0.21
- MACD
- HXHX 0.00
- NERV 0.03
- Stochastic Oscillator
- HXHX 0.00
- NERV 34.87
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.